Clinical Protocol to Prevent Thrombogenic Effect of Liver-Derived Mesenchymal Cells for Cell-Based Therapies

Louise Coppin*, Mustapha Najimi, Julie Bodart, Marie-Sophie Rouchon, Patrick van der Smissen, Stephane Eeckhoudt, Geraldine Dahlqvist, Diego Castanares-Zapatero, Mina Komuta, Sanne L. Brouns, Constance C. Baaten, Johan W. M. Heemskerk, Sandrine Horman, Nathalie Belmonte, Etienne Sokal, Xavier Stephenne

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number846
Number of pages16
JournalCells
Volume8
Issue number8
DOIs
Publication statusPublished - Aug 2019

Keywords

  • cell- and tissue-based therapy
  • liver transplantation
  • mesenchymal stem cells
  • thrombosis
  • anticoagulants
  • STEM-CELLS
  • PROCOAGULANT ACTIVITY
  • TISSUE FACTOR
  • BONE-MARROW
  • THROMBUS FORMATION
  • ACUTE DECOMPENSATION
  • TRANSPLANTATION
  • DISEASE
  • FAILURE
  • SAFETY

Cite this